Experience with labetalol in essential hypertension

Area of Science:

• Cardiovascular medicine
• Pharmacology

Background:

• Hypertension is a prevalent condition requiring effective management.
• Labetalol is an alpha- and beta-adrenergic blocker used for hypertension.

Purpose of the Study:

• To assess the efficacy of labetalol in patients with mild to moderate hypertension.
• To determine optimal dosage and treatment duration for labetalol therapy.

Main Methods:

• A randomized, placebo-controlled trial involving 73 patients.
• Patients received labetalol (200 mg daily, increased to 400 mg if needed) for 8 weeks.
• Blood pressure and heart rate were monitored throughout the study.

Main Results:

• Labetalol significantly reduced systolic and diastolic blood pressure (mean reduction of 22/12 mmHg).
• Eighty percent of patients achieved adequate blood pressure control.
• Heart rate decreased significantly from 78 to 69 bpm.

Conclusions:

• Labetalol is an effective treatment for mild to moderate hypertension.
• The drug demonstrates a favorable safety profile with manageable side effects.
• Further research may explore long-term efficacy and safety.